APA (7th ed.) Citation

P, K., NF, S., A, M., Y, L., AM, K., JJ, B., . . . DM, S. (2025). Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up. Head & neck, 47(9), 2594. https://doi.org/10.1002/hed.28178

Chicago Style (17th ed.) Citation

P, Kim, Saba NF, McCook-Veal A, Liu Y, Klein AM, Beitler JJ, Chen A, Khuri FR, and Shin DM. "Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up." Head & Neck 47, no. 9 (2025): 2594. https://doi.org/10.1002/hed.28178.

MLA (9th ed.) Citation

P, Kim, et al. "Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up." Head & Neck, vol. 47, no. 9, 2025, p. 2594, https://doi.org/10.1002/hed.28178.